The selection of enzyme blend is critical for the success of human islet isolations. Liberase HI collagenase (Roche) was introduced in the 1990s and had been widely used for clinical islet transplantation. More recently, a blend collagenase NB1 has been rendered available. The aim of this study was to evaluate the isolation outcomes and islet quality comparing human islet cells processed using NB1 and Liberase HI. A total of 90 isolations processed using NB1 (n = 40) or Liberase HI (n = 50) was retrospectively analyzed. Islet yield, function in vitro and in vivo, cellular (including β-cell-specific) viability and content, as well as isolation-related factors were compared. No significant differences in donor-related factors were found between the groups. There were also no significant differences in islet yields (NB1 vs. Liberase: 263,389 ± 21,550 vs. 324,256 ± 27,192 IEQ; p = n.s., respectively). The pancreata processed with NB1 showed a significantly longer digestion time (18.6 ± 0.7 vs. 14.5 ± 0.5 min, p < 0.01), lower β-cell viability (54.3 ± 3.4% vs. 72.0 ± 2.1%, p < 0.01), β-cell mass (93,671 ± 11,150 vs. 148,961 ± 12,812 IEQ, p < 0.01), and viable βcell mass (47,317 ± 6,486 vs. 106,631 ± 10,228 VβIEQ, p < 0.01) than Liberase HI. In addition, islets obtained with Liberase showed significantly better graft function in in vivo assessment of islet potency. The utilization of collagenase NB1 in human islet isolation was associated with significantly lower β-cell viability, mass, and islet potency in vivo in our series when compared to Liberase HI, even though there was no significant difference in islet yields between the groups. Evaluation of viable β-cell mass contained in human islet preparations will be useful for selecting enzyme blends.
INTRODUCTION
The critical procedure of islet isolation is a mechanically enhanced enzymatic digestion of the pancreas, which allows dissociation and freeing of the islets from Despite the widespread use of glucose monitoring and new insulin formulations, many individuals with the surrounding acinar tissue (27, 38) . Collagenase plays a crucial role in dissociating the pancreas during enzy-diabetes still develop devastating secondary complications such as retinopathy, nephropathy, neuropathy, and matic digestion phase. Liberase HI collagenase (Liberase; Boeringer-Mannheim/Roche) has been utilized as a cardiovascular disease (12, 21) . The recent developments and improvements in islet transplantation-related tech-standard blend for clinical islet transplantation since 1994 (28). More recently, the collagenase NB1 blend nology and immunosuppressant medications allow restoring near normal glucose control in patients with brittle (SERVA) has been rendered available and utilized for clinical trials in human islet isolation. type 1 diabetes with minimal risk of serious hypoglycemic episodes that are associated with intensive insulin Incidentally, concerns on the potential risks of contamination of the animal tissues utilized in the manufacturing therapy (7, 13, 18, 33, 41, 42) . 40 MISAWA ET AL.
of Liberase HI led to the decision to voluntarily suspend the main pancreatic duct with a pump that automatically adjusts the flow rate to maintain constant pressure (38). its use for clinical-grade human islet cell products worldwide. Thus, the only alternative option for clinical After achievement of pancreas distension, seven to nine pieces were transferred into a digestion chamber with use became collagenase NB1. This conversion created substantial effects on islet transplant activity through the sig-the same dissociation solution. The chamber was gently shaken to allow the pancreas to dissociate by both inter-nificant fluctuation of islet yield and quality.
In this study, we retrospectively analyzed and com-nal and external mechanical and enzymatic digestion. The digested pancreatic tissue was diluted, collected, pared human islet isolations processed using Liberase HI and collagenase NB1 blends in terms of isolation out-and washed three times with chilled solutions. The islets were purified with either only continuous or continuous comes, isolation-related factors, and islet quality. Our β-cell-specific islet assessment methods revealed signifi-following discontinuous density gradients using a COBE 2991 Cell Processor (Gambro Laboratories, Denver, cantly better quality of islets processed using Liberase HI, even though classic assessment methods such as flu-CO) at 4°C (17,32). Islet yield and purity were determined by dithizone (DTZ) staining (37) . Islet counts orescein diacetate (FDA)/propidium iodide (PI) could not distinguish differences in islet yield.
were obtained before (pre) and after (post) purification as well as after culture by scoring islets with incremental MATERIALS AND METHODS diameter size ranges and data expressed in islet particulate number (IPN) and islet equivalent number (IEQ). Human pancreata from multiorgan donors with consent for research and/or clinical use were processed Fractional β-Cell Viability Assay deceased at the Human Islet Cell Processing Facility of Fractional β-cell viability was determined using flow the Diabetes Research Institute at the University of cytometry, as previously reported (15, 19, 20 the dead cells (7-AAD − ) were excluded from further Human Islet Isolation analysis, live β-cells (NG bright ) were analyzed for mitochondrial membrane potential (TMRE), which allows All islet isolations were performed using a modified discriminating between viable (TMRE + ) and apoptotic automated method with the same protocol, as described (TMRE − ) cells. Apoptosis was evaluated selectively in previously (38). Briefly, pancreata were immersed in an the NG bright cell population. The percentage of TMRE + antibiotic solution prior to removing the surrounding on live β-cells (NG bright ) subset was determined based on vascular and adipose tissues. After cleaning, the panthe gate of TMRE unstained samples. creas was cut at the neck dividing the pancreas into two portions, the head and tail. Two 16-gauge catheters were Cellular Composition Assay then inserted into the main pancreatic duct of both pan-
The content of α-, β-, δand pancreatic polypeptide creas portions. The dissociation buffer containing either cells was determined by laser scanning cytometry (LSC/ collagenase NB1 or Liberase HI blend was perfused into iCys; CompuCyte, Cambrige, MA), as previously described (15,16). Briefly, dispersed cells were fixed on glass slides with 2.5% paraformaldehyde (Electron Micros- Sigma, St. Louis, MO), rabbit polyclonal antibody to islet aliquots exposed to high glucose to that of the high glucose. somatostatin (1:500 dilution, Dako North America Inc., Carpinteria, CA), and rabbit polyclonal antibody to pan-In Vivo Assessment of Islet Potency creatic polypeptide (PP; 1:1000 dilution, Dako). After washing in Optimax Wash Buffer (Bio-Genex, San Animal procedures were approved by the Institu-Ramon, CA), cells were incubated at room temperature tional Animal Care and Use Committee (IACUC), and for 1 h with Alexa Fluor 488 goat anti-mouse IgG (1: performed in the DRI's Preclinical Cell Processing and 200 dilution, Molecular Probes, Eugene, OR), Alexa Translational Models Core. Athymic nu/nu (nude) mice Fluor 647 goat anti-mouse IgG (1:200 dilution, Molecu-(Harlan Laboratories, Indianapolis, IN) were housed in lar Probes) antibodies, and 4′,6-diamidino-2-phenylinvirus/antibody-free rooms in microisolated cages, havdole (DAPI) (17 µl/ml, Molecular Probes). The percentage ing free access to autoclaved chow and water. Animals of α-, β-, δ-, and pancreatic polypeptide cells was autowere rendered diabetic via intravenous administration of matically calculated with LSC/iCys software.
200 mg/kg of streptozotocin (Sigma). Nonfasting blood glucose was assessed with a glucometer (OneTouch
Calculation of β-Cell Content Within Islets
Ultra2; Life Scan, Milpitas, CA). Mice with sustained and Absolute β-Cell Mass hyperglycemia (>300 mg/dl) were used as islet graft Based on the analysis of immunostaining for endorecipients. Islet grafts of 2,000 IEQ each were implanted crine cell markers by LSC/iCys, each parameter was calunder the left kidney capsule, as previously described culated using the formulas:
(15). Collectively, 41 mice received islet grafts from 33 human preparations processed using collagenase NB1 F1: β-cell content within islets = β-cell %/ and 40 mice received islets from 26 human preparations (α+β+δ+PP cell %) × 100 (%) isolated with Liberase enzyme blend. Average percentage of transplanted mice that reverted diabetes per F2: β-cell mass (βIEQ) = β-cell content human islet preparation and days required to reverse diabetes were assessed (17). within islet (%) × total IEQ appropriate to each specific analysis including Student's Viability Staining t-tests for two-sample comparisons of independent groups After culture, 50-100 IEQ were transferred to a 5-ml and Bonferroni correction followed by ANOVA for sixcentrifuge tube and settled for 2-3 min. After removal sample comparison. Statistical significance was considof the supernatant, the settled islets were collected and ered for values of p < 0.05. resuspended in phosphate-buffered saline (PBS) and placed into a 35 × 10-mm petri dish. The islets were RESULTS stained, in the dark, with 0.46 µM FDA and 14.34 µM Characteristics of Donors PI. Fifty individual and consecutively stained islets were
Statistical Analysis
The donor characteristics in each group are shown in assessed for percent viability by estimating the ratio of Table 2 . There was no significant difference in age, genviable (green fluorescence) versus nonviable (red fluoder ratio (male/female), body height, body weight, body rescence) cells using a fluorescent microscope, as described mass index (BMI), cold ischemia time (CIT), and panpreviously (30).
creas weight between the two groups.
Glucose-Stimulated Insulin Release
Isolation-Related Variables To determine the in vitro potency of islets, a static glucose challenge was performed as previously described
The islet isolation-related variables in each group are summarized in Table 3 . The digestion time in the colla-(15). Briefly, after overnight culture, islets (50-100 IEQ) were incubated in parallel with either 2.8 or 20 genase NB1 group was significantly longer, when compared with the Liberase group (18.6 ± 0.7 vs. 14.5 ± 0.5 mM glucose in culture medium for 2 h at 37°C. At the end of the incubation period, the supernatant was col-min, p < 0.01). There was no significant difference in the undigested pancreas weight and in the postpurifica-lected for insulin assessment by ELISA (Alpco, Salem, NH). A glucose stimulated insulin index was calculated tion islet yields between the two groups. There was also no significant difference between the groups in terms of by dividing the insulin content in the supernatant of the β-Cell Content and Islet Mass. To assess the effects of the two enzyme blends on β-cell content/mass contained in each human islet preparation, we obtained sinthe transplant rate and successful isolation rate (postpugle islet cell suspensions and stained them for pancreatic rification islet yield: more than 250,000 IEQ) (Liberase hormones ( Table 4 ). The β-cell content and β-cell mass vs. NB1: 54.5% vs. 36.8%, p = n.s., 52.9% vs. 41.2%, (βIEQ) for each islet preparation were calculated. The p = n.s., respectively). However, there were statistically Liberase group showed significantly higher β-cell consignificant differences between the two groups in the tent within islets than the NB1 group (46.3 ± 1.6% vs. post-and prepurification islet particle number (prepurifi-33.4 ± 2.0%; p < 0.01). The β-cell mass in the Liberase cation: 405,965 ± 21,910 vs. 315,178 ± 27,609, p < group was also significantly higher than in the NB1 0.05; postpurification: 270,986 ± 19,870 vs. 188,731 ± group (148,451 ± 12,812 vs. 91,351 ± 11,150 βIEQ, p < 19,732, p < 0.05, in Liberase and NB1, respectively). 0.01), even though there was no significant difference in The average size of the islets (IEQ/IPN) pre-and total islet yield between the two groups.Moreover, there postpurification in the Liberase group was significantly was significant difference between the groups in terms smaller than those in NB1 group (prepurification: 1.13 ± of the viable β-cell mass (VβIEQ), which was most 0.07 vs. 1.31 ± 0.10, p = 0.053; postpurification: 1.28 ± associated with in vivo islet potency (Liberase vs. NB1: 0.10 vs. 1.53 ± 0.10, p < 0.05, in Liberase and NB1, 106,274 ± 10,228 vs. 47,317 ± 6,486 VβIEQ, p < 0.01) respectively), even though the NB1 group had signifi- Fig. 1A-C ). cantly longer digestion times. The results suggested that enzymatic activity of NB1 might be lower when com-Islet Potency pared to that of Liberase. However, there were no signif-In Vitro: Glucose Stimulation Insulin Index. The gluicant differences between the two groups in the percentage cose stimulation insulin index in the NB1 group was of embedded islets recovered (Liberase vs. NB1: 13.9 ± significantly lower than in the Liberase group (1.65 ± 1.9 vs. 13.8 ± 2.5, p = n.s.). 0.22 vs. 2.37 ± 0.21, p < 0.01) ( Table 4 ).
Islet Quality
In Vivo: Islet Potency in the Diabetic Nude Mouse Model. The average reversal rates of diabetes in trans-Viability. To examine the effects of the two different collagenase blends on islet quality, islet preparations planted mice in the Liberase and NB1 groups were 81% and 69%, respectively (p = n.s.) ( Fig. 2A) . Although apoptotic cells (15). Moreover, islets in the Liberase group demonstrated significantly better quality islet there was no significant difference in the reversal rate, it took significantly more days to reverse diabetes in the potency, both in vitro and in vivo. Our results consistently indicated that the quality of islets processed using NB1 group than in the Liberase group (p < 0.05) (Fig. 2B) .
the collagenase NB1 blend was not as good as that of DISCUSSION islets processed using Liberase HI, even through islets yields were comparable. Evaluation of viable β-cell In this study, we have compared the effects of two clinical-grade collagenase blends, Liberase and NB1, on mass contained in human islet preparations will be of assistance for selecting enzyme blends. islet yield and β-cell quality in human islet isolations. Although islet yields assessed by DTZ staining were Since C. histolyticum collagenase became commercially available in the early 1960s, it has been widely comparable between the two groups, β-cell mass assessed by C-peptide staining in the Liberase group used as a tissue-dispersing enzyme (14, 24, 34) . A variety of collagenases/proteases produced by this technology was significantly higher. Assessment of islet cell viability by FDA/PI, which has been the gold standard method allows for degrading various types of collagen and gelatin. Therefore, enzyme derived from C. histolyticum is used for ongoing clinical trials, did not detect any differences in the viability of islets between the two groups.
called "crude collagenase" (11). The Liberase HI was introduced in November 1994 as the first dissociation However, the Liberase group showed significantly higher β-cell-specific viability than the NB1 group when enzyme blend developed to isolate human islets (26, 28, 36) . This product contained purified collagenase viability was assessed by fluorescence-activated cell sorting (FACS), which allows evaluating both dead and (both class I and II) from C. histolyticum and a purified bacterial neutral protease (thermolysin or Dispase) to a detrimental environment. Notably, Libease HI has also been reported to have lot-to-lot variability (4,35, (28) . The development of Liberase HI has dramatically changed human islet isolation (28), contributing to 43). A large-scale, multicenter study may be needed to assess the impact of lot-to-lot variability of the NB1 blend. obtaining reproducibly high numbers of islets from large animal pancreata, including human, and establishing Anazawa et al. recently reported the comparison between Liberase HI and NB1 blends utilized for clini-human islet transplantation as an option of therapies for patients with type 1 diabetes (41). This has been attrib-cal auto-islet transplantation for patients with chronic pancreatitis (2) . They demonstrated that total islet yields uted in part to the activity and purity of the enzyme blend, as well as to its low endotoxin contamination (5) .
with no purification in both groups were similar, and that the percentage of embedded islets was significantly Thus, Liberase HI had been used for clinical islet isolation until it was discontinued due to the potential, albeit higher in the NB1 group compared to the Liberase group. The purification procedure is not always neces-low, risk of prion disease transmission. Since then, collagenase NB1 has been utilized as the only enzyme sary for auto-islet transplantation unless the volume of whole islet preparation is high, which may increase the blend available for clinical purposes.
Several groups have reported the comparison between risk of intrahepatic thromboembolic events (31). However, in allogeneic islet transplantation, the purification Liberase HI and collagenase NB1 blends in terms of the efficiency of islet isolations yield and islet quality (2,8- process is a key for successful islet isolation and to reduce the volume of antigenic tissue implanted into the 10,39). Recently Brandhorst et al. reported that collagenase NB1 is less efficient for pancreas dissociation recipients. Even though the purification protocols have been improved in recent years, it still remains difficult than Liberase HI, describing that it may be less harmful to pancreatic tissues (8) , and that the glucose-stimulated to separate embedded islets from exocrine tissue when compared to non-embedded islets (3, 17, 32) . This phe-insulin release index and insulin content were significantly higher than in the Liberase group. In our study, nomenon might have contributed to the lower transplant rate registered in the islet isolation processed using NB1 we did not observe significant difference in terms of islet yields from human pancreata. In agreement with blend. In human islet isolation, purifying islets from other pancreatic tissue had been challenging until the the previous report, we observed that both β-cell mass and VβIEQ in the NB1 group were significantly lower large-scale purification method using COBE 2991 cell processor was reported (1, 25) . The selection of the puri-than in the Liberase group. Furthermore, both in vitro and in vivo islet function in the NB1 groups were signif-fication method or medium might be a possible explanation of the discrepancy among islet processing centers. icantly lower than in the Liberase group.
One possible explanation in the discrepancy between Neutral proteases have been recently reported to play an important role in enzymatic digestion (6, 7, 22, 23) . their report and our data may be related to lot-to-lot variability in the NB1 collagenase blend. In particular, a Kin et al. reported that the optimization of the neutral protease dosage based on pancreas weight rather than on total of nine different lots of NB1 blend were used in our study and, among them, five were utilized more than class II/class I collagenase activity ratio was more crucial in successful islet isolation (23) . Furthermore, they four times. Although these data were not conclusive due to the small number of samples, there were significant developed a pancreas digestion protocol optimized for NB1 enzyme, where only collagenase was injected into differences observed in islet yield and β-cell mass (islet yield A: 491,625 ± 70,906, B: 269,765 ± 56,087, C: the pancreas through the duct, and then neutral protease was added to the circulating system during the digestion 257,603 ± 6,048, D: 259,622 ± 38,262, E: 241,012 ± 69,536 IEQ, ANOVA, p = 0.055; β-cell mass A: phase (22) . Liberase HI and NB1 blends have different types of neutral proteases. Little data have been avail-193,913 ± 32,620, B: 49,349 ± 13,504, C: 75,779 ± 25,749, D: 103,953 ± 22,491, E: 101,659 ± 37,073 able to date in regards to the effects of neutral proteases on human islet quality and isolation yields. Although βIEQ, ANOVA, p < 0.01; Bonferroni correction A vs. C, D: p < 0.05). In fact, the highest β-cell mass in lot A neutral protease will be useful for shortening the digestion time through helping the dissociation of pancreatic was comparable to the one in the Liberase group (n.s.). As others reported (2), our data also showed signifi-tissues, it may be toxic for islet cells. However, it may be beneficial for islet cells through the degradation of cantly longer digestion times in the NB1 group. The longer exposure of pancreatic tissues to active enzyme active collagenase I/II. Further study addressing these issues will be needed. at high temperature (37°C) results in lower islet viability through enzymatic toxicity and hypoxia (29, 40) . Even
In conclusion, the present study demonstrated that the utilization of collagenase NB1 blend was associated though NB1 blend might be less harmful to islet cells, some of the lots tested showed less potency in terms of with significantly decreased β-cell mass, viability, and function when compared to Liberase, even though islet pancreas dissociation, which exposed the tissue longer 
